Prolastin

alpha-1 proteinase inhibitor (human) · Grifols Therapeutics LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Prolastin, covering 2014-08-21 to 2021-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19 [Phase 2]